Association of Relative Telomere Length and Risk of High Human Papillomavirus Load in Cervical Epithelial Cells

1 Herrmann M, Pusceddu I, März W, Herrmann W. Telomere biology and age-related diseases. Clin Chem Lab Med. 2018; 56(8): 1210–1222. HerrmannM PuscedduI MärzW HerrmannW Telomere biology and age-related diseases Clin Chem Lab Med 2018 56 8 1210 1222 10.1515/cclm-2017-087029494336 Search in Google Scholar

2 Armstrong CA, Tomita K. Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells. Open Biol. 2017;7(3): 160338. ArmstrongCA TomitaK Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells Open Biol 2017 7 3 160338 10.1098/rsob.160338537670928330934 Search in Google Scholar

3 Bernal A, Tusell L. Telomeres: Implications for Cancer Development. Int J Mol Sci. 2018; 19(1): 294. BernalA TusellL Telomeres: Implications for Cancer Development Int J Mol Sci 2018 19 1 294 10.3390/ijms19010294579623929351238 Search in Google Scholar

4 Zhu X, Han W, Xue W, Zou Y, Xie C, Du J, et al. The association between telomere length and cancer risk in population studies. Sci Rep. 2016; 6(1): 22243. ZhuX HanW XueW ZouY XieC DuJ The association between telomere length and cancer risk in population studies Sci Rep 2016 6 1 22243 10.1038/srep22243476810026915412 Search in Google Scholar

5 Caocci G, Greco M, Delogu G, Secchi C, Martino B, Labate C, et al. Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients. J Hematol Oncol. 2016; 9(1): 63. CaocciG GrecoM DeloguG SecchiC MartinoB LabateC Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients J Hematol Oncol 2016 9 1 63 10.1186/s13045-016-0293-y496680027473052 Search in Google Scholar

6 Okamoto K, Seimiya H. Revisiting Telomere Shortening in Cancer. Cells. 2019; 8(2): 107. OkamotoK SeimiyaH Revisiting Telomere Shortening in Cancer Cells 2019 8 2 107 10.3390/cells8020107640635530709063 Search in Google Scholar

7 Srinivas N, Rachakonda S, Kumar R. Telomeres and Telomere Length: A General Overview. Cancers (Basel). 2020; 12(3): 558. SrinivasN RachakondaS KumarR Telomeres and Telomere Length: A General Overview Cancers (Basel) 2020 12 3 558 10.3390/cancers12030558713973432121056 Search in Google Scholar

8 Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med. 2016; 8(1): 69. JafriMA AnsariSA AlqahtaniMH ShayJW Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies Genome Med 2016 8 1 69 10.1186/s13073-016-0324-x491510127323951 Search in Google Scholar

9 Shay JW. Role of Telomeres and Telomerase in Aging and Cancer. Cancer Discov. 2016; 6(6): 584–593. ShayJW Role of Telomeres and Telomerase in Aging and Cancer Cancer Discov 2016 6 6 584 593 10.1158/2159-8290.CD-16-0062489391827029895 Search in Google Scholar

10 Pańczyszyn A, Boniewska-Bernacka E, Głąb G. Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis. Mol Diagn Ther. 2018; 22(4): 421–430. PańczyszynA Boniewska-BernackaE GłąbG Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis Mol Diagn Ther 2018 22 4 421 430 10.1007/s40291-018-0336-x606142529777397 Search in Google Scholar

11 Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012; 285(3): 771–777. VinodhiniK ShanmughapriyaS DasBC NatarajaseenivasanK Prevalence and risk factors of HPV infection among women from various provinces of the world Arch Gynecol Obstet 2012 285 3 771 777 10.1007/s00404-011-2155-822159694 Search in Google Scholar

12 Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J cancer. 2012; 131(10): 2349–2359. GuanP Howell-JonesR LiN BruniL de SanjoséS FranceschiS Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer Int J cancer 2012 131 10 2349 2359 10.1002/ijc.2748522323075 Search in Google Scholar

13 Wang X, Huang X, Zhang Y. Involvement of Human Papillomaviruses in Cervical Cancer. Front Microbiol. 2018; 9: 2896. WangX HuangX ZhangY Involvement of Human Papillomaviruses in Cervical Cancer Front Microbiol 2018 9 2896 10.3389/fmicb.2018.02896627987630546351 Search in Google Scholar

14 Park Y, Kim T-J, Hwang C-S, Cho CH, Jeong DH, Seong SJ, et al. Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study. J Gynecol Oncol. 2019; 30(3). doi:10.3802/jgo.2019.30.e50. ParkY KimT-J HwangC-S ChoCH JeongDH SeongSJ Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study J Gynecol Oncol 2019 30 3 10.3802/jgo.2019.30.e50 642484330887765 Open DOISearch in Google Scholar

15 Suligoi B, Vittori G, Salfa MC, Timelli L, Corsini D, Fattorini G, et al. Prevalence and incidence of external genital warts in a sample of Italian general female population. BMC Infect Dis. 2017; 17(1): 126. SuligoiB VittoriG SalfaMC TimelliL CorsiniD FattoriniG Prevalence and incidence of external genital warts in a sample of Italian general female population BMC Infect Dis 2017 17 1 126 10.1186/s12879-017-2202-6529473628166736 Search in Google Scholar

16 Anorlu RI. What is the significance of the HPV epidemic? Can J Urol. 2008; 15(1): 3860–3865. AnorluRI What is the significance of the HPV epidemic? Can J Urol 2008 15 1 3860 3865 Search in Google Scholar

17 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424. BrayF FerlayJ SoerjomataramI SiegelRL TorreLA JemalA Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2018 68 6 394 424 10.3322/caac.2149230207593 Search in Google Scholar

18 Kombe AJK, Li B, Zahid A, Mengist HM, Bounda G-A, Zhou Y, et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Heal. 2020; 8. KombeAJK LiB ZahidA MengistHM BoundaG-A ZhouY Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation Front Public Heal 2020 8 10.3389/fpubh.2020.552028785597733553082 Search in Google Scholar

19 Zhang Y, Dakic A, Chen R, Dai Y, Schlegel R, Liu X. Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation. Oncotarget. 2017; 8(56): 96323–96339. ZhangY DakicA ChenR DaiY SchlegelR LiuX Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation Oncotarget 2017 8 56 96323 96339 10.18632/oncotarget.22036570710329221209 Search in Google Scholar

20 Molano M, Martín D, Moreno-Acosta P, Hernández G, Cornall A, Buitrago O, et al. Telomerase activity in cervical scrapes of women with high-grade cervical disease: A nested case-control study. Oncol Lett. 2017; 15(1): 354–360. MolanoM MartínD Moreno-AcostaP HernándezG CornallA BuitragoO Telomerase activity in cervical scrapes of women with high-grade cervical disease: A nested case-control study Oncol Lett 2017 15 1 354 360 10.3892/ol.2017.7324576807329387223 Search in Google Scholar

21 Ustaoglu M, Bektas A, Bedir A, Bakir T, Duzgun A, Nar R, et al. The telomere length of gastric mucosal samples and peripheral blood lymphocytes in patients who have undergone Billroth II distal gastrectomy. Arch Med Sci. 2020; 16(3): 577–583. UstaogluM BektasA BedirA BakirT DuzgunA NarR The telomere length of gastric mucosal samples and peripheral blood lymphocytes in patients who have undergone Billroth II distal gastrectomy Arch Med Sci 2020 16 3 577 583 10.5114/aoms.2020.94656721221132399105 Search in Google Scholar

22 Federal Budget Institute of Science Central Research Institute for Epidemiology. Guidelines to AmpliSens HPV HCR screen-titre-FRT PCR kit. Available at: https://interlabservice.ru/upload/iblock/a5b/Guidelines%20to%20AmpliSens%C2%AE%20HPV%20HCR%20screen-titre-FRT%20PCR%20kit%20(update%2028.07.2021).pdf.2018. Federal Budget Institute of Science Central Research Institute for Epidemiology. Guidelines to AmpliSens HPV HCR screen-titre-FRT PCR kit Available at: https://interlabservice.ru/upload/iblock/a5b/Guidelines%20to%20AmpliSens%C2%AE%20HPV%20HCR%20screen-titre-FRT%20PCR%20kit%20(update%2028.07.2021).pdf.2018 Search in Google Scholar

23 Federal Budget Institute of Science Central Research Institute for Epidemiology. AmpliSens HPV HCR genotype-titre-FRT PCR kit Instruction Manual. available at: http://www.theranostica.co.il/wp-content/uploads/2015/12/HPV-HCR-genotype-FRT-211212.pdf. 2018. Federal Budget Institute of Science Central Research Institute for Epidemiology. AmpliSens HPV HCR genotype-titre-FRT PCR kit Instruction Manual available at: http://www.theranostica.co.il/wp-content/uploads/2015/12/HPV-HCR-genotype-FRT-211212.pdf. 2018 Search in Google Scholar

24 Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30(10): 47e – 47. CawthonRM Telomere measurement by quantitative PCR Nucleic Acids Res 2002 30 10 47e 47 10.1093/nar/30.10.e47 Search in Google Scholar

25 Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2^ (–delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013; 3(3): 71. RaoX HuangX ZhouZ LinX An improvement of the 2^ (–delta delta CT) method for quantitative real-time polymerase chain reaction data analysis Biostat Bioinforma Biomath 2013 3 3 71 Search in Google Scholar

26 Wang L, Wang P, Ren Y, Du J, Jiang J, Jia X, et al. Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China. PLoS One. 2016; 11(8):e0160698. WangL WangP RenY DuJ JiangJ JiaX Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China PLoS One 2016 11 8 e0160698 10.1371/journal.pone.0160698 Search in Google Scholar

27 Luo H, Belinson JL, Du H, Liu Z, Zhang L, Wang C, et al. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening. J Low Genit Tract Dis. 2017; 21(1): 12–16. LuoH BelinsonJL DuH LiuZ ZhangL WangC Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening J Low Genit Tract Dis 2017 21 1 12 16 10.1097/LGT.0000000000000277 Search in Google Scholar

28 Boscolo-Rizzo P, Rampazzo E, Polesel J, Giunco S, Menegaldo A, Mantovani M, et al. Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma. Sci Rep. 2019; 9(1): 17572. Boscolo-RizzoP RampazzoE PoleselJ GiuncoS MenegaldoA MantovaniM Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma Sci Rep 2019 9 1 17572 10.1038/s41598-019-54028-x Search in Google Scholar

29 Plug-DeMaggio AW, Sundsvold T, Wurscher MA, Koop JI, Klingelhutz AJ, McDougall JK. Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6. Oncogene. 2004; 23(20): 3561–3571. Plug-DeMaggioAW SundsvoldT WurscherMA KoopJI KlingelhutzAJ McDougallJK Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6 Oncogene 2004 23 20 3561 3571 10.1038/sj.onc.1207388 Search in Google Scholar

30 Zhang A, Wang J, Zheng B, Fang X, Ångström T, Liu C, et al. Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene. 2004; 23(44): 7441–7447. ZhangA WangJ ZhengB FangX ÅngströmT LiuC Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix Oncogene 2004 23 44 7441 7447 10.1038/sj.onc.1207527 Search in Google Scholar

31 Rudolph KL, Millard M, Bosenberg MW, DePinho RA. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet. 2001; 28(2): 155–159. RudolphKL MillardM BosenbergMW DePinhoRA Telomere dysfunction and evolution of intestinal carcinoma in mice and humans Nat Genet 2001 28 2 155 159 10.1038/88871 Search in Google Scholar

32 O’Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, Chin L, et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2002; 2(2): 149–155. O’HaganRC ChangS MaserRS MohanR ArtandiSE ChinL Telomere dysfunction provokes regional amplification and deletion in cancer genomes Cancer Cell 2002 2 2 149 155 10.1016/S1535-6108(02)00094-6 Search in Google Scholar

33 Dong L, Wang MZ, Zhao X, Feng R, Hu S, Zhang Q, et al. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papilloma-virus positive women: A prospective screening cohort study. Gynecol Oncol. 2018; 148(1): 103–110. DongL WangMZ ZhaoX FengR HuS ZhangQ Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papilloma-virus positive women: A prospective screening cohort study Gynecol Oncol 2018 148 1 103 110 10.1016/j.ygyno.2017.11.01629169614 Search in Google Scholar

34 Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer. 2003; 103(4): 519–524. SchlechtNF TrevisanA Duarte-FrancoE RohanTE FerenczyA VillaLL Viral load as a predictor of the risk of cervical intraepithelial neoplasia Int J Cancer 2003 103 4 519 524 10.1002/ijc.1084612478669 Search in Google Scholar

35 Zhang D, Chen J, Hong C, Yi D, Wang F, Cui W. High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis. Cancer. 2014; 120(17): 2673–2683. ZhangD ChenJ HongC YiD WangF CuiW High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis Cancer 2014 120 17 2673 2683 10.1002/cncr.2879724840723 Search in Google Scholar

36 Castro-Duque AF, Loango-Chamorro N, Ruiz-Hoyos BM, Landázuri P. Telomerase activity associated with progression of cervical lesions in a group of Colombian patients. Rev Bras Ginecol e Obs. 2015; 37(12): 559–564. Castro-DuqueAF Loango-ChamorroN Ruiz-HoyosBM LandázuriP Telomerase activity associated with progression of cervical lesions in a group of Colombian patients Rev Bras Ginecol e Obs 2015 37 12 559 564 10.1590/SO100-72032015000546226647844 Search in Google Scholar

37 Pańczyszyn A, Boniewska-Bernacka E, Głąb G. Telomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection. Taiwan J Obstet Gynecol. 2020; 59(1): 51–55. PańczyszynA Boniewska-BernackaE GłąbG Telomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection Taiwan J Obstet Gynecol 2020 59 1 51 55 10.1016/j.tjog.2019.11.00732039800 Search in Google Scholar